Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Published : May-2019

No. of Pages : 302

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transmucosal Drug Delivery Devices Overview
3 Products under Development
3.1 Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
4 Transmucosal Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
5 Transmucosal Drug Delivery Devices Companies and Product Overview
5.1 AcelRx Pharmaceuticals Inc Company Overview
5.2 Aegis Therapeutics LLC Company Overview
5.3 AFYX Therapeutics A/S Company Overview
5.4 Albert Einstein College of Medicine Company Overview
5.5 Allergan Plc Company Overview
5.6 Amphastar Pharmaceuticals Inc Company Overview
5.7 Aquestive Therapeutics Inc Company Overview
5.8 ARS Pharmaceuticals Inc Company Overview
5.9 Auritec Pharmaceuticals Inc Company Overview
5.10 BeFree! Company Overview
5.11 Bespak Europe Ltd Company Overview
5.12 Biorings LLC Company Overview
5.13 BioXcel Therapeutics Inc Company Overview
5.14 Callitas Therapeutics Inc Company Overview
5.15 Columbia University Company Overview
5.16 Combinent BioMedical Systems Inc Company Overview
5.17 Conrad Company Overview
5.18 Dare Bioscience Inc Company Overview
5.19 Emergent BioSolutions Inc Company Overview
5.20 Evestra Inc Company Overview
5.21 Evofem Biosciences Inc Company Overview
5.22 Evoke Pharma Inc Company Overview
5.23 EyeGate Pharmaceuticals Inc Company Overview
5.24 Ferring Pharmaceuticals AS Company Overview
5.25 Ghent University Company Overview
5.26 Glenmark Pharmaceuticals Ltd Company Overview
5.27 Hebrew University of Jerusalem Company Overview
5.28 INSYS Therapeutics Inc Company Overview
5.29 IntelGenx Corp Company Overview
5.30 Janssen Research & Development LLC Company Overview
5.31 Karessa Pharma AB Company Overview
5.32 Kytogenics Pharmaceuticals Inc Company Overview
5.33 Laboratoire HRA Pharma SAS Company Overview
5.34 Laboratorios Andromaco Company Overview
5.35 Lyra Therapeutics Company Overview
5.36 McNeil AB Company Overview
5.37 Medlab Clinical Ltd Company Overview
5.38 Merck & Co Inc Company Overview
5.39 Merck Serono SA Company Overview
5.40 Merck Sharp & Dohme Ltd Company Overview
5.41 Mithra Pharmaceuticals SA Company Overview
5.42 Mystic Pharmaceuticals Inc Company Overview
5.43 Nanosys Inc Company Overview
5.44 NorInvent AB Company Overview
5.45 Novus Therapeutics Inc Company Overview
5.46 Oak Crest Institute of Science Company Overview
5.47 Opiant Pharmaceuticals Inc Company Overview
5.48 OptiNose AS Company Overview
5.49 Orion Biotechnology Canada Ltd Company Overview
5.50 Orphanse Healthcare SAS Company Overview
5.51 Palette Life Sciences AB Company Overview
5.52 Phoenix Life Sciences International Ltd Company Overview
5.53 Privo Technologies LLC Company Overview
5.54 Promius Pharma LLC Company Overview
5.55 RDD Pharma Ltd Company Overview
5.56 Renown Pharma Ltd Company Overview
5.57 Rhinomed Ltd Company Overview
5.58 Scientus Pharma Inc Company Overview
5.59 Shenox Pharmaceuticals LLC Company Overview
5.60 Shin Nippon Biomedical Laboratories Ltd Company Overview
5.61 Suda Pharmaceuticals Ltd Company Overview
5.62 Texas Tech University Company Overview
5.63 The Hong Kong University of Science and Technology Company Overview
5.64 Therakind Ltd Company Overview
5.65 TherapeuticsMD Inc Company Overview
5.66 Tiziana Life Sciences PLC Company Overview
5.67 UCB SA Company Overview
5.68 University of North Carolina at Chapel Hill Company Overview
5.69 University of Pittsburgh Company Overview
5.70 University of South Florida Company Overview
5.71 University of Texas at Austin Company Overview
5.72 University of the Witwatersrand Company Overview
5.73 University of Washington Company Overview
5.74 Washington University in St Louis Company Overview
6 Transmucosal Drug Delivery Devices - Recent Developments
6.1 Apr 30, 2019: Aptar reports first quarter results
6.2 Apr 30, 2019: In 2018, Marinomed set the course for accelerated growth
6.3 Apr 08, 2019: Opiant Pharmaceuticals announces publication of clinical pharmacokinetic data supporting potential of OPNT003, nasal nalmefene, for treatment of synthetic opioid overdose
6.4 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
6.5 Apr 04, 2019: IntelGenx Presents at 14th International Conference on Alzheimer's and Parkinson's Disease
6.6 Mar 29, 2019: World-renowned scientist, described as the edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Dare Bioscience scientific advisory board
6.7 Mar 25, 2019: INSYS Therapeutics to present poster of pharmacokinetic study of Naloxone novel nasal spray at The College on Problems of Drug Dependence Annual Scientific Meeting
6.8 Mar 25, 2019: TherapeuticsMD announces oral and poster presentations on ANNOVERA at the Endocrine Society 2019 Annual Meeting
6.9 Mar 21, 2019: Aptar Pharma to showcase new market innovations at Interphex 2019, New York City
6.10 Mar 20, 2019: Superior Psychiatric Services announces new services and products for Depression treatment
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 2: Transmucosal Drug Delivery Devices - Pipeline Products by Segment
Table 3: Transmucosal Drug Delivery Devices - Pipeline Products by Territory
Table 4: Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Transmucosal Drug Delivery Devices - Ongoing Clinical Trials
Table 7: Transmucosal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 9: AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: ARX-02 Sufentanil NanoTab BTP Management System - Product Status
Table 11: ARX-02 Sufentanil NanoTab BTP Management System - Product Description
Table 12: ARX-03 Sufentanil/Trazolam NanoTab - Product Status
Table 13: ARX-03 Sufentanil/Trazolam NanoTab - Product Description
Table 14: ZALVISO - Product Status
Table 15: ZALVISO - Product Description
Table 16: AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 17: ZALVISO - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
Table 18: ZALVISO - Usability and Satisfaction Evaluation of Sufentanil Sublingual Patient-controlled Analgesia after Elective Surgery with Moderate-to-severe Postoperative Pain
Table 19: Aegis Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: VALTOCO Nasal Spray - Product Status
Table 21: VALTOCO Nasal Spray - Product Description
Table 22: Aegis Therapeutics LLC - Ongoing Clinical Trials Overview
Table 23: VALTOCO Nasal Spray - A 12-month Open-label, Repeat-dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
Table 24: VALTOCO Nasal Spray - An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
Table 25: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Rivelin Combo Patch - Product Status
Table 27: Rivelin Combo Patch - Product Description
Table 28: AFYX Therapeutics A/S - Ongoing Clinical Trials Overview
Table 29: Rivelin Combo Patch - A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intra-orally Twice Daily in Patients with Oral Lichen Planus (OLP) Using Rivelin-CLO Patches
Table 30: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Drug-Impregnated Intravaginal Ring - Product Status
Table 32: Drug-Impregnated Intravaginal Ring - Product Description
Table 33: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Vaginal Ring Contraceptive - Product Status
Table 35: Vaginal Ring Contraceptive - Product Description
Table 36: Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Intranasal Naloxone Spray - Product Status
Table 38: Intranasal Naloxone Spray - Product Description
Table 39: Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: APL-130277 Sublingual Soluble Film - Product Status
Table 41: APL-130277 Sublingual Soluble Film - Product Description
Table 42: AQST-108 Sublingual Soluble Film - Product Status
Table 43: AQST-108 Sublingual Soluble Film - Product Description
Table 44: AQST-119 Oral Soluble Film - Product Status
Table 45: AQST-119 Oral Soluble Film - Product Description
Table 46: AQST-305 Buccal Soluble Film - Product Status
Table 47: AQST-305 Buccal Soluble Film - Product Description
Table 48: Diazepam (Libervant) Buccal Film - Product Status
Table 49: Diazepam (Libervant) Buccal Film - Product Description
Table 50: Exservan - Product Status
Table 51: Exservan - Product Description
Table 52: Aquestive Therapeutics Inc - Ongoing Clinical Trials Overview
Table 53: Diazepam (Libervant) Buccal Film - A Multicenter, Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects with Epilepsy
Table 54: ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: ARS-1 - Product Status
Table 56: ARS-1 - Product Description
Table 57: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Versa Intravaginal Ring - Acromegaly - Product Status
Table 59: Versa Intravaginal Ring - Acromegaly - Product Description
Table 60: Versa Intravaginal Ring - Alzheimer's Disease - Product Status

1.2 List of Figures
Figure 1: Transmucosal Drug Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Transmucosal Drug Delivery Devices - Pipeline Products by Segment
Figure 3: Transmucosal Drug Delivery Devices - Pipeline Products by Territory
Figure 4: Transmucosal Drug Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Transmucosal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Transmucosal Drug Delivery Devices - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027